Skip to content

COLECALCIFEROL

DRUG13 trials

Sponsors

Calcilytix Therapeutics Inc., Fondazione Italiana Linfomi Ets, Karolinska University Hospital, Karolinska Institutet, Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Medical University Of Vienna

Conditions

Allergisk RinitAutosomal Dominant Hypocalcemia Type 1 (ADH1)Deficiency, Vitamin DElderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)Fatigue in patients with colorectal cancer (CRC) (ICD codes C18-C20 and C21.8) within 12 months after a colorectal cancer therapy (surgeryHIV InfectionsHyperparathyroidism, SecondaryHypogonadism

Phase 2

Phase 3

Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors
TerminatedNCT02419105
University of ZurichHypogonadism, Pre-frail Seniors
Start: 2015-09-30End: 2020-06-30Updated: 2020-06-18
CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1)
RecruitingCTIS2022-501398-38-00
Calcilytix Therapeutics Inc.Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Start: 2023-09-02Target: 34Updated: 2026-01-16
Prephase treatment with prednisone +/- Vitamin D supplementation followed by immunochemotherapy in Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL). A randomized, open label, phase III study by Fondazione Italiana Linfomi.
Active, not recruitingCTIS2024-511637-35-00
Fondazione Italiana Linfomi EtsElderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)
Start: 2021-03-23Target: 430Updated: 2024-11-18
Personalized Vitamin D Supplementation for Reducing or Preventing Fatigue and Enhancing Quality of Life of Patients with Colorectal Tumor: Randomized Intervention Trial (VICTORIA)
CompletedCTIS2024-515420-37-01
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechtschemotherapy and/or radiation) and not optimal vitamin D status (25-hydroxyvitamin D (25(OH)D) levels < 60 nmol/L), Fatigue in patients with colorectal cancer (CRC) (ICD codes C18-C20 and C21.8) within 12 months after a colorectal cancer therapy (surgery
Start: 2020-09-28End: 2025-07-15Target: 456Updated: 2025-01-17

Phase 4

Unknown Phase

Related Papers